Early use of mammalian target of rapamycin inhibitors is an independent risk factor for incisional hernia development after liver transplantation.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 21987434)

Published in Liver Transpl on February 01, 2012

Authors

Roberto Montalti1, Antonio Mimmo, Gianluca Rompianesi, Valentina Serra, Nicola Cautero, Roberto Ballarin, Nicola De Ruvo, Robert Cunningham Gerring, Giorgio Enrico Gerunda, Fabrizio Di Benedetto

Author Affiliations

1: Liver and Multivisceral Transplant Center, University of Modena and Reggio Emilia, Modena, Italy. robertomontalti@yahoo.it

Articles by these authors

Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl (2002) 2.18

Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation (2002) 1.95

Genetic variants regulating immune cell levels in health and disease. Cell (2013) 1.86

Kabuki syndrome and cancer in two patients. Am J Med Genet A (2010) 1.62

Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. Transplantation (2005) 1.59

First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation (2010) 1.58

Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie (2009) 1.58

Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol (2005) 1.48

Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol (2011) 1.46

Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation. J Laparoendosc Adv Surg Tech A (2012) 1.40

Intermittent gastric outlet obstruction due to a gallstone migrated through a cholecysto-gastric fistula: a new variant of "Bouveret's syndrome". World J Gastroenterol (2008) 1.30

Impact of biliary complications in right lobe living donor liver transplantation. Transpl Int (2006) 1.23

Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res (2011) 1.18

Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist (2011) 1.14

Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc (2007) 1.12

Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg (2010) 0.98

Adenocarcinoid tumor of the extrahepatic biliary tract. Int J Surg Pathol (2008) 0.98

Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. Transplantation (2011) 0.97

Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl (2004) 0.96

Liver metastases from colorectal cancer: present surgical approach. Hepatogastroenterology (2003) 0.95

Wernicke's encephalopathy in a malnourished surgical patient: a difficult diagnosis. BMC Res Notes (2014) 0.93

Primary squamous cell carcinoma of the liver associated with Caroli's disease: a case report. Onkologie (2011) 0.93

Cystic pancreatic neuroendocrine neoplasms with uncertain malignant potential: report of two cases. Surg Today (2009) 0.93

Use of a branch patch with the cystic artery in living-related liver transplantation. Clin Transplant (2004) 0.91

Intestinal transplantation for chronic intestinal pseudo-obstruction in adult patients. Am J Transplant (2004) 0.89

A new endoscopic treatment for pancreatic fistula after distal pancreatectomy: case report and review of the literature. Gastrointest Endosc (2008) 0.89

Do not deny pancreatic resection to elderly patients. J Gastrointest Surg (2008) 0.88

Results of salvage liver transplantation. Liver Int (2014) 0.88

Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol (2007) 0.88

Intraportal hepatocyte transplantation in the pig: hemodynamic and histopathological study. Transplantation (2002) 0.87

Liver resection for colorectal metastases in older adults: a paired matched analysis. J Am Geriatr Soc (2011) 0.86

HHV-6A in syncytial giant-cell hepatitis. N Engl J Med (2008) 0.86

Unusual paraneoplastic syndrome accompanies neuroendocrine tumours of the pancreas. Case Rep Med (2011) 0.86

Total abdominal approach for postero-superior segments (7, 8) in laparoscopic liver surgery: a multicentric experience. Updates Surg (2015) 0.86

A new reconstruction of the accessory donor right hepatic artery with interposition of the SMA in liver transplantation. Surgery (2006) 0.86

Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma. Endocrine (2013) 0.85

Banked depopulated vena caval homograft: a new strategy to restore caval continuity. Surg Innov (2011) 0.84

Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients. Oncologist (2013) 0.83

Two-stage liver transplantation: an effective procedure in urgent conditions. Clin Transplant (2009) 0.82

Intestinal autotransplantation for adenocarcinoma of pancreas involving the mesenteric root: our experience and literature review. Pancreas (2007) 0.82

Successful liver transplantation using a severely injured graft. J Trauma (2007) 0.81

Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs (2013) 0.81

Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients. Transplantation (2005) 0.81

Intermittent inflow occlusion in living liver donors: impact on safety and remnant function. Liver Transpl (2004) 0.80

Clinical experience with pheochromocytoma in a single centre over 16 years. High Blood Press Cardiovasc Prev (2013) 0.80

Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol (2006) 0.80

Reconstruction of the suprahepatic cuff injured during multiorgan procurement using the infrahepatic vena cava of the liver allograft. Liver Transpl (2007) 0.79

Immunological advantages of everolimus versus cyclosporin A in liver-transplanted recipients, as revealed by polychromatic flow cytometry. Cytometry A (2012) 0.79

Pancreatic resections for malignancy in patients aged 70 and older. J Am Geriatr Soc (2009) 0.79

Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol (2002) 0.79

The impact of human immunodeficiency virus infection in liver transplantation for hepatocellular carcinoma. Hepatology (2011) 0.79

Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol (2010) 0.78

Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Transplantation (2007) 0.78

Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: case report and review of the literature. Tumori (2008) 0.78

Simultaneous presence of focal nodular hyperplasia and hepatocellular carcinoma: case report and review of the literature. Tumori (2003) 0.78

Absence of viable HCC in the native liver is an independent protective factor of tumor recurrence after liver transplantation. Transplantation (2014) 0.78

Sorafenib before liver transplantation for hepatocellular carcinoma: risk or give up. Transpl Int (2011) 0.78

Is advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy? J Surg Oncol (2011) 0.78